2022
Drug use and severe outcomes among adults hospitalized with influenza, 2016–2019
Parisi C, Yousey‐Hindes K, Holstein R, O'Halloran A, Kirley P, Alden N, Anderson E, Kim S, McMahon M, Khanlian S, Spina N, Gaitan M, Shiltz E, Thomas A, Schaffner W, Talbot K, Crossland M, Cook R, Garg S, Meek J, Hadler J. Drug use and severe outcomes among adults hospitalized with influenza, 2016–2019. Influenza And Other Respiratory Viruses 2022, 17: e13052. PMID: 36300969, PMCID: PMC9835414, DOI: 10.1111/irv.13052.Peer-Reviewed Original ResearchConceptsSevere outcomesDrug useICU admissionMechanical ventilationInfluenza Hospitalization Surveillance NetworkInfluenza-associated outcomesSevere influenza outcomesPersistent public health problemChronic liver diseaseChronic lung diseasePublic health problemNon-Hispanic blacksLogistic regression modelsHispanics/LatinosSmoke tobaccoInfluenza vaccinationOpioid useImmunosuppressive conditionsInfluenza seasonSevere morbidityInfluenza infectionInfluenza outcomesLiver diseaseLung diseaseChronic conditions
2008
The mortality burden of chronic liver disease may be substantially underestimated in the United States.
Durante AJ, St Louis T, Meek JI, Navarro VJ, Sofair AN. The mortality burden of chronic liver disease may be substantially underestimated in the United States. Connecticut Medicine 2008, 72: 389-92. PMID: 18763665.Peer-Reviewed Original ResearchConceptsChronic liver diseaseICD-10 codesLiver diseaseEnd-stage liver diseaseStage liver diseaseDeath certificate dataCause of deathMedical examiner recordsCLD burdenCLD statusMedical chartsMortality burdenDeath certificatesCertificate dataHealth StatisticsCounty residentsDiseaseGold standardBurdenSerious diseaseDeathUnited States National CenterDetrimental effectsSpecificityPrevention